Overview of relevant actions in connection with a consultation in general practice for patients after screening for CV disease
| Low n (%) | High n (%) | P value | |
|---|---|---|---|
| Total | 833 (100) | 432 (100) | |
| Consultation at general practice | 590 (70.8) | 325 (75.2) | 0.10 |
| Consultation+other blood samples | 116 (13.9) | 63 (14.6) | 0.80 |
| Consultation+BP home measurement | 8 (1.0) | 28 (6.5) | <0.00 |
| Consultation+B-glucose | 39 (4.7) | 33 (7.6) | 0,04 |
| Consultation+first-time prescription* within 42 days of screening visit | |||
| Statins | 7 (0.8) | 16 (3.7) | <0.00 |
| Antihypertensives and antidiabetics | 6 (0.7) | 30 (6.9) | <0.00 |
| Consultations with a relevant action | 152 (18.2) | 124 (28.7) | <0.00 |
*First-time prescription is defined as a prescription for a medication the patient did not receive in the last 6 months prior to the screening visit.
B-glucose, blood-glucose; BP, blood pressure; CV, cardiovascular.